Related Experiment Videos

Myocardial ischemia-reperfusion injury in CD18- and ICAM-1-deficient mice

A J Palazzo1, S P Jones, W G Girod

  • 1Department of Molecular and Cellular Physiology, Louisiana State University Medical Center, Shreveport, Louisiana 71130-3392, USA.

Insights

Myocardial ischemia-reperfusion injury is reduced when neutrophils (PMNs) cannot interact with endothelial cells. Deficiencies in CD18 or ICAM-1 significantly decrease PMN infiltration and heart cell damage.

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Cell Biology

Background:

  • Circulating neutrophils (PMNs) play a role in myocardial ischemia-reperfusion (MI/R) injury.
  • PMN-endothelial cell adhesion is mediated by CD11/CD18 on PMNs and ICAM-1 on endothelial cells.

Purpose of the Study:

  • To investigate the role of CD18 and ICAM-1 in MI/R injury.
  • To determine the impact of CD18 and ICAM-1 deficiency on PMN infiltration and myocardial necrosis.

Main Methods:

  • Myocardial ischemia-reperfusion injury was induced in wild-type, CD18-deficient, and ICAM-1-deficient mice.
  • PMN infiltration and myocardial infarction size were quantified.

Main Results:

  • Myocardial infarction was significantly reduced in CD18-deficient (19.3%) and ICAM-1-deficient (17.9%) mice compared to wild-type (45.1%).
  • PMN infiltration was reduced by 54% in CD18-deficient and 32% in ICAM-1-deficient mice.

Conclusions:

  • CD18 and ICAM-1 are critical for PMN infiltration during MI/R injury.
  • Targeting CD18-ICAM-1 interactions may reduce myocardial necrosis and improve outcomes after MI/R.

Related Concept Videos